Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Boston Therapeutics, Inc. | 25,178,958 | reported | 09 Dec 2022 | tx 39+202,014,102 |
| ELLIE MAE INC | 1,810,734 | reported | 20 Apr 2011 | tx 24+1,851,881−2,178,958 |
| ASK JEEVES INC | 1,587,815 | reported | 10 Sept 2004 | tx 25+114,000−802,000 |
| NeurogesX Inc | 0 | reported | 07 May 2007 | tx 5+1,735,673−26,035,188 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2022 | PURCHASE | Boston Therapeutics, Inc. | 7,380 | 0.25 USD | |
| 09 Dec 2022 | PURCHASE | Boston Therapeutics, Inc. | 2,620 | 0.25 USD | |
| 10 Jun 2022 | PURCHASE | Boston Therapeutics, Inc. | 355,609 | — | deriv |
| 10 Jun 2022 | PURCHASE | Boston Therapeutics, Inc. | 355,609 | 172222.00 USD | deriv |
| 25 May 2022 | PURCHASE | Boston Therapeutics, Inc. | 711,218 | — | deriv |
| 11 Oct 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |
| 10 Nov 2022 | PURCHASE | Boston Therapeutics, Inc. | — | 277778.00 USD | deriv |
| 10 Nov 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |
| 28 Nov 2022 | PURCHASE | Boston Therapeutics, Inc. | — | 166667.00 USD | deriv |
| 28 Nov 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |
| 22 Jun 2022 | PURCHASE | Boston Therapeutics, Inc. | 213,366 | — | deriv |
| 13 Jul 2022 | PURCHASE | Boston Therapeutics, Inc. | — | 194444.00 USD | deriv |
| 13 Jul 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |
| 27 Jul 2022 | PURCHASE | Boston Therapeutics, Inc. | — | 555556.00 USD | deriv |
| 27 Jul 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |
| 23 Aug 2022 | PURCHASE | Boston Therapeutics, Inc. | — | 555556.00 USD | deriv |
| 23 Aug 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |
| 25 May 2022 | PURCHASE | Boston Therapeutics, Inc. | 711,218 | 211111.00 USD | deriv |
| 22 Jun 2022 | PURCHASE | Boston Therapeutics, Inc. | 355,610 | 194444.00 USD | deriv |
| 19 May 2022 | PURCHASE | Boston Therapeutics, Inc. | 248,927 | — | deriv |
| 19 May 2022 | PURCHASE | Boston Therapeutics, Inc. | 248,927 | 16667.00 USD | deriv |
| 13 May 2022 | PURCHASE | Boston Therapeutics, Inc. | 220,478 | — | deriv |
| 13 May 2022 | PURCHASE | Boston Therapeutics, Inc. | 270,263 | 166667.00 USD | deriv |
| 09 Sept 2022 | PURCHASE | Boston Therapeutics, Inc. | — | 277778.00 USD | deriv |
| 09 Sept 2022 | PURCHASE | Boston Therapeutics, Inc. | — | — | deriv |